Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation

Autor: Jordi Camps, Anna Hernández-Aguilera, Jorge Joven, Anabel García-Heredia, Isabel Fort-Gallifa, Vicente Martín-Paredero, Noemí Cabré, Josep M. Simó, Fedra Luciano-Mateo
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Male
Pathology
Chemokine
Galectin 3
Femoral artery
030204 cardiovascular system & hematology
medicine.disease_cause
F2-isoprostanes
Pathogenesis
lcsh:Chemistry
0302 clinical medicine
Medicine
oxidative stress
Popliteal Artery
lcsh:QH301-705.5
Spectroscopy
biology
General Medicine
Middle Aged
Computer Science Applications
Femoral Artery
medicine.anatomical_structure
Galectin-3
Female
medicine.symptom
medicine.medical_specialty
Inflammation
peripheral artery disease
Catalysis
Article
Inorganic Chemistry
03 medical and health sciences
Peripheral Arterial Disease
medicine.artery
Adventitia
galectin-3
otorhinolaryngologic diseases
Humans
Physical and Theoretical Chemistry
Molecular Biology
Aged
business.industry
Organic Chemistry
Popliteal artery
stomatognathic diseases
030104 developmental biology
atherosclerosis
lcsh:Biology (General)
lcsh:QD1-999
Case-Control Studies
biology.protein
Endothelium
Vascular

business
Oxidative stress
Biomarkers
Zdroj: International Journal of Molecular Sciences, Vol 18, Iss 5, p 973 (2017)
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 18; Issue 5; Pages: 973
ISSN: 1422-0067
Popis: Galectin-3 is a modulator of oxidative stress, inflammation, and fibrogenesis involved in the pathogenesis of vascular diseases. The present study sought to characterize, in patients with peripheral artery disease (PAD), the localization of galectin-3 in arterial tissue, and to analyze the relationships between the circulating levels of galectin-3 and oxidative stress and inflammation. It also sought to compare the diagnostic accuracy of galectin-3 with that of other biochemical markers of this disease. We analyzed femoral or popliteal arteries from 50 PAD patients, and four control arteries. Plasma from 86 patients was compared with that from 72 control subjects. We observed differences in the expression of galectin-3 in normal arteries, and arteries from patients with PAD, with a displacement of the expression from the adventitia to the media, and the intima. In addition, plasma galectin-3 concentration was increased in PAD patients, and correlated with serologic markers of oxidative stress (F2-isoprostanes), and inflammation [chemokine (C−C motif) ligand 2, C-reactive protein, β-2-microglobulin]. We conclude that the determination of galectin-3 has good diagnostic accuracy in the assessment of PAD and compares well with other analytical parameters currently in use.
Databáze: OpenAIRE